Wearable Device Now Authorized to Support Diagnosis and Monitoring of Sleep Apnea and Related Health Conditions from the Comfort of Home

Non-invasive solution aims to tighten skin, accelerate healing, and reduce incontinence through targeted muscle stimulation

Revolutionary platform integrates augmented reality and artificial intelligence to enhance surgical training and anatomical education globally

Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.

Magnetic-Assisted Robotic Platform Now Approved for Bariatric and Hiatal Hernia Procedures, Broadening Access to Scar-Reducing Surgical Innovation

Johnson & Johnson MedTech (NYSE: JNJ)+
announced today that it launched new variable angle optimized locking technology (VOLT) plating systems.

BOSTON, June 18, 2025 /PRNewswire/ — CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced today that it has received Investigational Testing Authorization (ITA) from Health Canada to conduct the STRIDE trial, a clinical study evaluating CereVasc’s eShunt System as a treatment for normal pressure hydrocephalus (NPH).

SAN JOSE, Calif., June 18, 2025 /PRNewswire/ — Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system for the treatment of urinary urge incontinence (UUI).